![Philippe Pierre Goupit](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Philippe Pierre Goupit
Président chez
Tollys
Profil
Philippe Pierre Goupit is currently the Chairman at Tollys and also holds a Chairman position at Burgin & Co. He previously worked as a Director at Fovea Pharmaceuticals SA from 2010 to 2013, and as a Director at MedDay Pharmaceuticals SAS from 2014 to 2021.
He also served as an Independent Non-Executive Director at Lysogene SA and as an Independent Director at Inventiva SA from 2015 to 2017.
Prior to that, he worked at Sanofi for 20 years, where he held the position of Vice President-Mergers & Acquisitions.
Goupit obtained his undergraduate degree from Université de Paris 5 René Descartes.
Postes actifs de Philippe Pierre Goupit
| Sociétés | Poste | Début |
|---|---|---|
Tollys
 Tollys Hospital/Nursing ManagementHealth Services Provides cancer immunotherapy treatment solutions | Président | 01/04/2020 |
Burgin & Co. | Président | - |
Anciens postes connus de Philippe Pierre Goupit
| Sociétés | Poste | Fin |
|---|---|---|
MedDay Pharmaceuticals SAS
 MedDay Pharmaceuticals SAS BiotechnologyHealth Technology Operates as a biotechnology company developing new drugs for nervous system disorders | Directeur/Membre du Conseil | 01/01/2021 |
| INVENTIVA | Directeur/Membre du Conseil | 30/05/2017 |
| SANOFI | Investor Relations Contact | 01/12/2014 |
Fovea Pharmaceuticals SA
 Fovea Pharmaceuticals SA Pharmaceuticals: MajorHealth Technology Develops and commercializes drugs for the treatment of ocular diseases | Directeur/Membre du Conseil | 01/01/2013 |
| LYSOGENE | Directeur/Membre du Conseil | - |
Formation de Philippe Pierre Goupit
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
85
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Sanofi
 Sanofi Pharmaceuticals: MajorHealth Technology Engages in research, development and production of pharmaceuticals & vaccines | Health Technology |
Fovea Pharmaceuticals SA
Fovea Pharmaceuticals SA Pharmaceuticals: MajorHealth Technology Develops and commercializes drugs for the treatment of ocular diseases | Health Technology |
Université de Paris 5 René Descartes
 Université de Paris 5 René Descartes Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MedDay Pharmaceuticals SAS
MedDay Pharmaceuticals SAS BiotechnologyHealth Technology Operates as a biotechnology company developing new drugs for nervous system disorders | Health Technology |
Lysogene SA
 Lysogene SA BiotechnologyHealth Technology Engages in research and clinical development of gene therapy for neurodegenerative disorders | Health Technology |
Inventiva SA
 Inventiva SA BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops oral small molecule therapies for the treatment of MASH and other diseases | Health Technology |
Tollys
Tollys Hospital/Nursing ManagementHealth Services Provides cancer immunotherapy treatment solutions | Health Services |
Burgin & Co. |
